Renee Commerford

Affiliations

Early Clinical Development, Oncology, Genentech, South San Francisco, CA, USA.
Gilead Sciences, Foster City, CA, USA.

Réseau de co-auteurs

Voleak Choeurng 2 collaborations

Gail D Lewis 1 collaboration

Guangmin Li 1 collaboration

Jun Guo 1 collaboration

Shang-Fan Yu 1 collaboration

Carter T Fields 1 collaboration

Genee Lee 1 collaboration

Donglu Zhang 1 collaboration

Peter S Dragovich 1 collaboration

Thomas Pillow 1 collaboration

BinQing Wei 1 collaboration

Jack Sadowsky 1 collaboration

Douglas Leipold 1 collaboration

Tim Wilson 1 collaboration

Amrita Kamath 1 collaboration

Michael Mamounas 1 collaboration

M Violet Lee 1 collaboration

Ola Saad 1 collaboration

Alexander Ungewickell 1 collaboration

Sharareh Monemi 1 collaboration

Lisa Crocker 1 collaboration

Kevin Kalinsky 1 collaboration

Shanu Modi 1 collaboration

Kyung Hae Jung 1 collaboration

Erika Hamilton 1 collaboration

Patricia LoRusso 1 collaboration

Ian Krop 1 collaboration

Melissa M Schutten 1 collaboration

Mark X Sliwkowski 1 collaboration

Eunpi Cho 1 collaboration

Joyce Liu 1 collaboration

Howard Burris 1 collaboration

Judy S Wang 1 collaboration

Lisa Barroilhet 1 collaboration

Martin Gutierrez 1 collaboration

Yulei Wang 1 collaboration

Anjali Vaze 1 collaboration

Stephanie Royer-Joo 1 collaboration

Eric Humke 1 collaboration

Kathleen Moore 1 collaboration

Renee Commerford

Affiliations

Publications (2)

The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results.

An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer.

Réseau de co-auteurs